CutisPharma Announced New Oral Solution Compounding Kit

| By | Drug Compounding

CutisPharma, Inc. announced the commercial availability of FIRST-Atenolol grape-flavored oral solution compounding kit. FIRST-Atenolol provides pharmacists with a convenient, high-quality, standardized way to compound an oral liquid Atenolol solution for patients who are not otherwise served by commercially available therapies, such as those who are unable to swallow solid oral dosing formulations.

We are pleased to announce that, effective today, FIRST-Atenolol is available to all pharmacies in the United States. The addition of FIRST-Atenolol to our overall portfolio of FIRST Unit-of-Use Compounding Kits has been widely anticipated by our customers. This represents the second new addition to the family of FIRST Kits launched this year, after FIRST-Metoprolol, providing pharmacists with an expanded range of high-quality alternatives to traditionally compounded oral liquid suspensions and solutions,

said Mike Radice,
CutisPharma’s Chief Commercial Officer.

FIRST-Atenolol is now available in 2 mg/mL 300mL and 10 mg/mL 150 mL strengths to allow additional flexibility for a variety of patient needs.

GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.